Notice and Request for Comments on the Implications of Access and Benefit-Sharing (ABS) Regimes on Global Health and Biomedical Research, 26928-26929 [2019-12150]

Download as PDF 26928 Federal Register / Vol. 84, No. 111 / Monday, June 10, 2019 / Notices has sought an exemption under Section 312 of the Act and Section 107.730, Financings which Constitute Conflicts of Interest of the Small Business Administration (‘‘SBA’’) Rules and Regulations (13 CFR 107.730). Serra Capital (SBIC) III, L.P. provides convertible debt financing to SERIONX, INC. 14301 N 87th Street, Suite 116, Scottsdale, Arizona 85260. The financing is brought within the purview of § 107.730(a) of the Regulations because Serra Capital III, L.P. has previously invested $400,000 of convertible debt in SERIONX, INC. As this entity is considered an associate of Serra Capital (SBIC) III, L.P., this transaction Requires a prior SBA exemption. Notice is hereby given that any interested person may submit written comments on the transaction, within fifteen days of the date of this publication, to the Associate Administrator for Investment, U.S. Small Business Administration, 409 Third Street SW, Washington, DC 20416. A. Joseph Shepard, Associate Administrator, Office of Investment and Innovation. [FR Doc. 2019–12135 Filed 6–7–19; 8:45 am] BILLING CODE 8025–01–P SMALL BUSINESS ADMINISTRATION [Disaster Declaration #15975 and #15976; LOUISIANA Disaster Number LA–00092] Presidential Declaration of a Major Disaster for Public Assistance Only for the State of Louisiana U.S. Small Business Administration. ACTION: Notice. AGENCY: This is a Notice of the Presidential declaration of a major disaster for Public Assistance Only for the State of Louisiana (FEMA–4439– DR), dated 06/03/2019. Incident: Severe Storms and Tornadoes. Incident Period: 04/24/2019 through 04/25/2019. DATES: Issued on 06/03/2019. Physical Loan Application Deadline Date: 08/02/2019. Economic Injury (EIDL) Loan Application Deadline Date: 03/03/2020. ADDRESSES: Submit completed loan applications to: U.S. Small Business Administration, Processing and Disbursement Center, 14925 Kingsport Road, Fort Worth, TX 76155. FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster Assistance, khammond on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:45 Jun 07, 2019 Jkt 247001 these issues, on June 25 and September 20, 2019. Any future Meetings will be announced at https://www.state.gov/ bureaus-offices/under-secretary-foreconomic-growth-energy-and-theenvironment/bureau-of-oceans-andinternational-environmental-andscientific-affairs/office-of-internationalhealth-and-biodefense/. DATES: Written comments are welcome before each of the two planned public meetings referenced above and will be reviewed periodically beginning July 10, 2019. ADDRESSES: One submission per meeting is welcome, with no more than 10 pages of single-spaced text including relevant examples with no more than one page per example. Submissions should be made via the internet at Percent www.regulations.gov docket number DOS–2019–0016. For alternatives to For Physical Damage: online submissions, please contact Dr. Non-Profit Organizations with Credit Available Elsewhere ... 2.750 Jennifer Seedorff at (202) 647–3017 or Non-Profit Organizations withseedorffje@state.gov. Note that relevant out Credit Available Elsecomments submitted to regulations.gov where ..................................... 2.750 will be posted without editing and will For Economic Injury: be available to the public; therefore, Non-Profit Organizations withbusiness-confidential information out Credit Available Elsewhere ..................................... 2.750 should be clearly identified as such and submitted by email. The public is strongly encouraged to file submissions The number assigned to this disaster electronically rather than by facsimile or for physical damage is 15975B and for mail. economic injury is 159760. FOR FURTHER INFORMATION CONTACT: (Catalog of Federal Domestic Assistance Questions regarding the submission of Number 59008) comments should be directed to Dr. Rafaela Monchek, Jennifer Seedorff (202) 647–3017, Acting Associate Administrator for Disaster seedorffje@state.gov. Assistance. SUPPLEMENTARY INFORMATION: [FR Doc. 2019–12161 Filed 6–7–19; 8:45 am] Representatives from the Department of BILLING CODE 8206–03–P State will review written submissions and share them, as appropriate, with staff from other Federal Agencies to inform U.S. Government policy and our DEPARTMENT OF STATE international engagements on these [Public Notice: 10789] issues. U.S. officials may contact individuals making submissions for Notice and Request for Comments on the Implications of Access and Benefit- further information or explanation. In particular, we seek comments on and Sharing (ABS) Regimes on Global specific examples of the impacts of Health and Biomedical Research other countries’ implementation of the AGENCY: Department of State. Nagoya Protocol or other ABS measures SUMMARY: In order to inform U.S. on such issues as: International research Government policy and international collaborations, international pathogen engagement, the U.S. Department of sample sharing, infectious disease State (DOS) invites submission of research, including influenza, Zika and comments from the public, academia, other diseases, pandemic and epidemic relevant industries, and other interested preparedness and response, medical stakeholders on the implications of countermeasure product development Access and Benefit-Sharing (ABS) efforts, investor interest in vaccine regimes on global health and biomedical development, and other aspects. We research. In particular, DOS invites would also welcome views on what the comments related to the effects of World Health Organization (WHO), Nagoya Protocol and other ABS other UN bodies, and non-governmental implementation on public health organizations can do to effectively systems. The Department will hold at protect public health equities in the least two public meetings to discuss context of the Nagoya Protocol and U.S. Small Business Administration, 409 3rd Street SW, Suite 6050, Washington, DC 20416, (202) 205–6734. SUPPLEMENTARY INFORMATION: Notice is hereby given that as a result of the President’s major disaster declaration on 06/03/2019, Private Non-Profit organizations that provide essential services of a governmental nature may file disaster loan applications at the address listed above or other locally announced locations. The following areas have been determined to be adversely affected by the disaster: Primary Parishes: Lincoln, Morehouse, Union The Interest Rates are: PO 00000 Frm 00120 Fmt 4703 Sfmt 4703 E:\FR\FM\10JNN1.SGM 10JNN1 khammond on DSKBBV9HB2PROD with NOTICES Federal Register / Vol. 84, No. 111 / Monday, June 10, 2019 / Notices other national level ABS implementation. We also welcome examples of: (1) Monetary or non-monetary benefits to the global public health system that are facilitated by international sharing of pathogens, biospecimens, pathogen genetic sequence data, and/or relevant metadata. (2) Influenza-specific issues and/or examples related to the items described above or other items that could affect global influenza pandemic preparedness and response or efforts to combat seasonal influenza. (3) Non-ABS challenges and barriers with sharing pathogens internationally or that otherwise have significant implications for global pandemic or epidemic preparedness and response efforts that might merit additional attention or analysis. Background: Biological threats to the U.S. homeland—whether as the result of deliberate attack, accident, or a natural outbreak—are growing and require actions to address them at their source. Naturally emerging outbreaks of viruses such as Ebola and Severe Acute Respiratory Syndrome (SARS), as well as the deliberate 2001 anthrax attacks in the United States, demonstrated the impact of biological threats on national security by taking lives, generating economic losses, and contributing to a loss of confidence in government institutions. To effectively prepare for or respond to epidemic and pandemic infectious disease threats, the United States government and other public health actors need rapid, systematic, and consistent access to both information and samples from outbreaks, including pathogens, related clinical material, pathogen genetic sequence data, epidemiological data, and relevant metadata. The Global Influenza Surveillance and Response System and Pandemic Influenza Preparedness Framework facilitate the sharing of samples of influenza viruses and access to vaccines and other benefits. WHO is engaging with Member States, stakeholders, and other UN bodies to better understand the impacts of Nagoya Protocol and other ABS measures on public health, including the sharing of influenza and noninfluenza pathogens. Several meetings are planned in association with this request for written submissions. Time and Date: Two initial meetings are planned on Tuesday, June 25 and Friday, September 20, 2019. Each meeting will begin at 1:30 p.m. EDT and last for up to two hours. If the Department decides to hold additional VerDate Sep<11>2014 16:45 Jun 07, 2019 Jkt 247001 public meetings, the time and place will be announced on the Department website: https://www.state.gov/bureausoffices/under-secretary-for-economicgrowth-energy-and-the-environment/ bureau-of-oceans-and-internationalenvironmental-and-scientific-affairs/ office-of-international-health-andbiodefense/. Place: The two initial meetings will be held at the U.S. State Department’s Harry S. Truman Building, 2201 C Street NW, Washington, DC 20520. Please use the 21st Street entrance, and plan to arrive at least twenty minutes prior to the start of the meeting to allow for ID verification and escorting requirements. Status: The meetings will be open to the public. Persons planning on attending must provide their full name and organization to Dr. Jennifer Seedorff at seedorffje@state.gov and copy RSVPIHB@state.gov at least three days prior to each meeting. Persons who need special accommodations should also contact Dr. Seedorff at seedorffje@ state.gov or (202) 647–3017 and copy RSVP-IHB@state.gov at least seven days before each meeting. Requests made after that time will be considered, but might not be possible to accommodate. Personal data is requested pursuant to Public Law 99–399 (Omnibus Diplomatic Security and Antiterrorism Act of 1986), as amended; Public Law 107–56 (USA PATRIOT Act); and E.O. 13356. The purpose of the collection is to validate the identity of individuals who enter 1033 Department facilities. The data will be entered into the Visitor Access Control System (VACS–D) database. Please see the Security Records System of Records Notice (State-36) at https://www.state.gov/ documents/organization/242611.pdf for additional information. Dated June 4, 2019. Jerrold L. Mallory, Deputy Assistant Secretary for Science Space and Health (Acting), Bureau of Oceans and International Environmental and Scientific Affairs, Department of State. [FR Doc. 2019–12150 Filed 6–7–19; 8:45 am] BILLING CODE 4710–09–P SURFACE TRANSPORTATION BOARD [Docket No. AB 1273X] New York & Greenwood Lake Railway—Abandonment Exemption— in Bergen and Passaic Counties, N.J. New York & Greenwood Lake Railway (NYGL) has filed with the Surface Transportation Board (Board) a petition under 49 U.S.C. 10502 for exemption from the prior approval requirements of PO 00000 Frm 00121 Fmt 4703 Sfmt 4703 26929 49 U.S.C. 10903 to abandon 1.1 miles of rail line extending between milepost 0.0 and milepost 1.1 in Bergen and Passaic Counties, N.J. (the Line).1 The Line traverses U.S. Postal Service Zip Codes 07055 and 07026. According to NYGL, the Line was purchased in 2017 by Passaic Street Properties, LLC (PSP), through a tax foreclosure sale due to NYGL’s failure to pay federal taxes. In 2018, PSP filed a notice of exemption in Docket No. FD 36187 to acquire the Line, which NYGL opposed. The Board rejected PSP’s notice of exemption with respect to the Line.2 NYGL states that, thereafter, it entered into negotiations with PSP and that the parties have reached a settlement in which NYGL has agreed to abandon the Line. NYGL filed the petition for exemption in accordance with the settlement agreement. NYGL states that the Line has not had a significant amount of traffic since 2009 when its last customer went out of business. According to NYGL, starting in 2017, it renewed efforts to market the Line as a transload facility, and those efforts led to handling about eight carloads of traffic, which NYGL states is insufficient to produce a profit and enable NYGL to rehabilitate the trackage. NYGL states that PSP and the local governments wish to reclaim the right-of-way for urban redevelopment, and local planners seek to redevelop the area for residential and commercial purposes. In addition to an exemption from the provisions of 49 U.S.C. 10903, NYGL also seeks an exemption from the offer of financial assistance (OFA) procedures of 49 U.S.C. 10904. NYGL states that the submission of an OFA could defeat the very purpose for which this abandonment has been filed. NYGL’s request for exemption from section 10904 will be addressed in the final decision. According to NYGL, the Line does not contain federally granted rights-of-way, and any documentation in NYGL’s possession will be made available promptly to those requesting it. As a condition to this exemption, any employee adversely affected by the abandonment shall be protected under Oregon Short Line Railroad— Abandonment Portion Goshen Branch Between Firth & Ammon, in Bingham & 1 NYGL initially submitted its petition on April 24, 2019, but supplemented it on May 10, 2019, and again on May 21, 2019. In light of NYGL’s supplements, the petition is deemed to have been filed on May 21, 2019. 2 Passaic Street Props., LLC—Acquis. & Operation Exemption—N.Y. & Greenwood Lake Ry., FD 36187 (STB served July 18, 2018). E:\FR\FM\10JNN1.SGM 10JNN1

Agencies

[Federal Register Volume 84, Number 111 (Monday, June 10, 2019)]
[Notices]
[Pages 26928-26929]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12150]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice: 10789]


Notice and Request for Comments on the Implications of Access and 
Benefit-Sharing (ABS) Regimes on Global Health and Biomedical Research

AGENCY: Department of State.

SUMMARY: In order to inform U.S. Government policy and international 
engagement, the U.S. Department of State (DOS) invites submission of 
comments from the public, academia, relevant industries, and other 
interested stakeholders on the implications of Access and Benefit-
Sharing (ABS) regimes on global health and biomedical research. In 
particular, DOS invites comments related to the effects of Nagoya 
Protocol and other ABS implementation on public health systems. The 
Department will hold at least two public meetings to discuss these 
issues, on June 25 and September 20, 2019. Any future Meetings will be 
announced at https://www.state.gov/bureaus-offices/under-secretary-for-economic-growth-energy-and-the-environment/bureau-of-oceans-and-international-environmental-and-scientific-affairs/office-of-international-health-and-biodefense/.

DATES: Written comments are welcome before each of the two planned 
public meetings referenced above and will be reviewed periodically 
beginning July 10, 2019.

ADDRESSES: One submission per meeting is welcome, with no more than 10 
pages of single-spaced text including relevant examples with no more 
than one page per example. Submissions should be made via the internet 
at www.regulations.gov docket number DOS-2019-0016. For alternatives to 
online submissions, please contact Dr. Jennifer Seedorff at (202) 647-
3017 or [email protected]. Note that relevant comments submitted to 
regulations.gov will be posted without editing and will be available to 
the public; therefore, business-confidential information should be 
clearly identified as such and submitted by email. The public is 
strongly encouraged to file submissions electronically rather than by 
facsimile or mail.

FOR FURTHER INFORMATION CONTACT: Questions regarding the submission of 
comments should be directed to Dr. Jennifer Seedorff (202) 647-3017, 
[email protected].

SUPPLEMENTARY INFORMATION: Representatives from the Department of State 
will review written submissions and share them, as appropriate, with 
staff from other Federal Agencies to inform U.S. Government policy and 
our international engagements on these issues. U.S. officials may 
contact individuals making submissions for further information or 
explanation. In particular, we seek comments on and specific examples 
of the impacts of other countries' implementation of the Nagoya 
Protocol or other ABS measures on such issues as: International 
research collaborations, international pathogen sample sharing, 
infectious disease research, including influenza, Zika and other 
diseases, pandemic and epidemic preparedness and response, medical 
countermeasure product development efforts, investor interest in 
vaccine development, and other aspects. We would also welcome views on 
what the World Health Organization (WHO), other UN bodies, and non-
governmental organizations can do to effectively protect public health 
equities in the context of the Nagoya Protocol and

[[Page 26929]]

other national level ABS implementation. We also welcome examples of:
    (1) Monetary or non-monetary benefits to the global public health 
system that are facilitated by international sharing of pathogens, 
biospecimens, pathogen genetic sequence data, and/or relevant metadata.
    (2) Influenza-specific issues and/or examples related to the items 
described above or other items that could affect global influenza 
pandemic preparedness and response or efforts to combat seasonal 
influenza.
    (3) Non-ABS challenges and barriers with sharing pathogens 
internationally or that otherwise have significant implications for 
global pandemic or epidemic preparedness and response efforts that 
might merit additional attention or analysis.
    Background: Biological threats to the U.S. homeland--whether as the 
result of deliberate attack, accident, or a natural outbreak--are 
growing and require actions to address them at their source. Naturally 
emerging outbreaks of viruses such as Ebola and Severe Acute 
Respiratory Syndrome (SARS), as well as the deliberate 2001 anthrax 
attacks in the United States, demonstrated the impact of biological 
threats on national security by taking lives, generating economic 
losses, and contributing to a loss of confidence in government 
institutions. To effectively prepare for or respond to epidemic and 
pandemic infectious disease threats, the United States government and 
other public health actors need rapid, systematic, and consistent 
access to both information and samples from outbreaks, including 
pathogens, related clinical material, pathogen genetic sequence data, 
epidemiological data, and relevant metadata. The Global Influenza 
Surveillance and Response System and Pandemic Influenza Preparedness 
Framework facilitate the sharing of samples of influenza viruses and 
access to vaccines and other benefits. WHO is engaging with Member 
States, stakeholders, and other UN bodies to better understand the 
impacts of Nagoya Protocol and other ABS measures on public health, 
including the sharing of influenza and non-influenza pathogens.
    Several meetings are planned in association with this request for 
written submissions.
    Time and Date: Two initial meetings are planned on Tuesday, June 25 
and Friday, September 20, 2019. Each meeting will begin at 1:30 p.m. 
EDT and last for up to two hours. If the Department decides to hold 
additional public meetings, the time and place will be announced on the 
Department website: https://www.state.gov/bureaus-offices/under-secretary-for-economic-growth-energy-and-the-environment/bureau-of-oceans-and-international-environmental-and-scientific-affairs/office-of-international-health-and-biodefense/.
    Place: The two initial meetings will be held at the U.S. State 
Department's Harry S. Truman Building, 2201 C Street NW, Washington, DC 
20520. Please use the 21st Street entrance, and plan to arrive at least 
twenty minutes prior to the start of the meeting to allow for ID 
verification and escorting requirements.
    Status: The meetings will be open to the public. Persons planning 
on attending must provide their full name and organization to Dr. 
Jennifer Seedorff at [email protected] and copy [email protected] 
at least three days prior to each meeting. Persons who need special 
accommodations should also contact Dr. Seedorff at [email protected] 
or (202) 647-3017 and copy [email protected] at least seven days 
before each meeting. Requests made after that time will be considered, 
but might not be possible to accommodate. Personal data is requested 
pursuant to Public Law 99-399 (Omnibus Diplomatic Security and 
Antiterrorism Act of 1986), as amended; Public Law 107-56 (USA PATRIOT 
Act); and E.O. 13356. The purpose of the collection is to validate the 
identity of individuals who enter 1033 Department facilities. The data 
will be entered into the Visitor Access Control System (VACS-D) 
database. Please see the Security Records System of Records Notice 
(State-36) at https://www.state.gov/documents/organization/242611.pdf 
for additional information.

    Dated June 4, 2019.
Jerrold L. Mallory,
Deputy Assistant Secretary for Science Space and Health (Acting), 
Bureau of Oceans and International Environmental and Scientific 
Affairs, Department of State.
[FR Doc. 2019-12150 Filed 6-7-19; 8:45 am]
BILLING CODE 4710-09-P